用电子健康记录数据确定多发性骨髓瘤患者生存差异的决定因素
Wanting Cui1, Joseph Finkelstein1
1Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Studies in health technology and informatics
|January 25, 2024
概括
老年人,非裔美国患者和患有III期多发性骨髓瘤 (MM) 的人面临更短的生存期. 这项研究分析了MM患者的数据,以确定关键的生存因素.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 流行病学 流行病学
背景情况:
- 多发性骨髓瘤 (MM) 是一种流行的血液性恶性瘤.
- 了解影响MM患者生存的因素对于临床管理至关重要.
研究的目的:
- 分析影响多发性骨髓瘤患者长期和短期生存的社会人口学,经济和遗传因素.
- 使用电子健康记录 (EHR) 数据识别生存预测因素.
主要方法:
- 从2,111名多发性骨髓瘤患者的EHR数据进行了回顾性分析.
- 将患者分为长期和短期生存组进行分层.
- 描述性统计和后勤回归分析人口变量,癌症阶段,收入和遗传突变.
主要成果:
- 年龄,种族和癌症阶段是多发性骨髓瘤存活率的重要预测因素.
- 年龄较大,非洲裔美国人种族和第三阶段癌症与生存时间较短有关.
- 在多变量分析中,性别和收入水平没有显示统计学意义.
结论:
- 社会人口学因素,特别是年龄,种族和癌症阶段,显著影响多发性骨髓瘤患者的生存率.
- 临床干预和研究应考虑这些因素,以改善高风险MM患者的治疗结果.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
188
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
188
Cancer Survival Analysis
348
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
348
Kaplan-Meier Approach
141
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
141
Assumptions of Survival Analysis
128
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
128
Actuarial Approach
79
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
79
Methods of Documentation VII: EMR
836
Electronic Medical Records (EMRs) primarily center around electronically documenting patients' health information within a single healthcare organization or practice. They contain essential clinical data related to a patient's medical history, diagnoses, medications, treatment plans, lab results, and other pertinent information relevant to the specific encounter or episode of care. EMRs are designed to streamline documentation and workflow processes within individual healthcare...
836


